This morning we watched UnitedHealth drop -9.0% to a price of $551.01 per share. The Large-Cap Medical Specialities company is now trading -11.93% below its average target price of $625.66. Analysts have set target prices ranging from $568.01 to $680.0 per share for UnitedHealth, and have given the stock an average rating of buy.
UnitedHealth's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.9%. The stock's short ratio is 2.58. The company's insiders own 0.23% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 89.5%. In conclusion, we believe there is mixed market sentiment regarding UnitedHealth.
Institutions Invested in UnitedHealth
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-06-30 | Vanguard Group Inc | 9% | 83,948,358 | $46,254,704,954 |
| 2024-06-30 | Blackrock Inc. | 8% | 73,428,872 | $40,458,573,466 |
| 2024-06-30 | State Street Corporation | 5% | 44,976,548 | $24,781,627,743 |
| 2024-06-30 | FMR, LLC | 4% | 32,697,703 | $18,016,107,056 |
| 2024-06-30 | Capital World Investors | 3% | 28,023,012 | $15,440,399,108 |
| 2024-06-30 | Price (T.Rowe) Associates Inc | 3% | 26,020,604 | $14,337,092,343 |
| 2024-06-30 | Wellington Management Group, LLP | 3% | 25,883,509 | $14,261,554,371 |
| 2024-06-30 | JP Morgan Chase & Company | 3% | 24,348,903 | $13,416,001,826 |
| 2024-06-30 | Morgan Stanley | 2% | 20,052,563 | $11,048,761,491 |
| 2024-06-30 | Geode Capital Management, LLC | 2% | 19,318,665 | $10,644,391,039 |
